NEW YORK (GenomeWeb) – Imperial College London has launched a new branch of the Parkinson's Progression Markers Initiative, a large-scale biomarker research project sponsored by the Michael J. Fox Foundation for Parkinson's Research that will focus on two mutations linked to the disease, the foundation said today.

The PPMI will study individuals with known LRRK or SNCA genetic mutations, both of which have been linked to Parkinson's disease, and it is currently seeking volunteers of Ashkenazi Jewish background to participate in the project.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.